Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-01

Clinical Trial Update: Dexmedetomidine Versus Propofol for Sedation in Stereotactic Brain Biopsy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing dexmedetomidine and propofol for sedation in stereotactic brain biopsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • PROPOFOL (Propofol)

Snippet

Sponsor: Ain Shams University | Conditions: Adverse Effects in the Therapeutic Use of Other and Unspecified Agents Primarily Acting on the Respiratory System | Phase 4 | Status: COMPLETED